VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 115 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250 | -34.6% | 58,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $382 | -64.9% | 58,000 | -63.9% | 0.00% | 0.0% |
| Q1 2023 | $1,089 | +175.7% | 160,500 | +200.0% | 0.00% | 0.0% |
| Q4 2022 | $395 | -99.9% | 53,500 | +17.3% | 0.00% | 0.0% |
| Q3 2022 | $450,000 | -9.5% | 45,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $497,000 | +2.3% | 45,600 | +6.0% | 0.00% | 0.0% |
| Q1 2022 | $486,000 | +71.7% | 43,000 | +137.6% | 0.00% | +100.0% |
| Q4 2021 | $283,000 | -12.1% | 18,100 | -3.7% | 0.00% | 0.0% |
| Q3 2021 | $322,000 | -20.3% | 18,800 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $404,000 | +58.4% | 18,800 | +10.6% | 0.00% | 0.0% |
| Q1 2021 | $255,000 | -38.1% | 17,000 | -45.9% | 0.00% | -50.0% |
| Q4 2020 | $412,000 | -32.8% | 31,400 | -50.6% | 0.00% | -33.3% |
| Q3 2020 | $613,000 | +2.9% | 63,500 | +21.9% | 0.00% | 0.0% |
| Q2 2020 | $596,000 | -0.8% | 52,100 | -10.3% | 0.00% | 0.0% |
| Q1 2020 | $601,000 | -20.5% | 58,100 | +26.0% | 0.00% | 0.0% |
| Q4 2019 | $756,000 | -45.5% | 46,100 | -55.8% | 0.00% | 0.0% |
| Q3 2019 | $1,386,000 | +93.8% | 104,400 | +105.5% | 0.00% | 0.0% |
| Q2 2019 | $715,000 | -8.6% | 50,800 | +19.5% | 0.00% | -25.0% |
| Q1 2019 | $782,000 | -9.5% | 42,500 | +28.4% | 0.00% | 0.0% |
| Q4 2018 | $864,000 | -8.1% | 33,100 | -19.3% | 0.00% | 0.0% |
| Q3 2018 | $940,000 | +4.0% | 41,000 | -13.7% | 0.00% | 0.0% |
| Q2 2018 | $904,000 | +24.0% | 47,500 | +9.7% | 0.00% | +33.3% |
| Q1 2018 | $729,000 | -14.6% | 43,300 | -23.0% | 0.00% | -25.0% |
| Q4 2017 | $854,000 | +8.2% | 56,200 | +27.4% | 0.00% | +33.3% |
| Q3 2017 | $789,000 | +0.9% | 44,100 | -8.1% | 0.00% | 0.0% |
| Q2 2017 | $782,000 | +12.7% | 48,000 | -3.2% | 0.00% | 0.0% |
| Q1 2017 | $694,000 | -8.2% | 49,600 | +4.6% | 0.00% | 0.0% |
| Q4 2016 | $756,000 | +2.9% | 47,400 | +7.2% | 0.00% | 0.0% |
| Q3 2016 | $735,000 | +6.5% | 44,200 | -28.4% | 0.00% | 0.0% |
| Q2 2016 | $690,000 | +7.8% | 61,700 | -19.5% | 0.00% | 0.0% |
| Q1 2016 | $640,000 | – | 76,627 | – | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2014 | $861,000 | -35.7% | 60,100 | -53.4% | 0.00% | +33.3% |
| Q3 2014 | $1,340,000 | +249.9% | 129,000 | +444.3% | 0.00% | +50.0% |
| Q2 2014 | $383,000 | +6.7% | 23,700 | +7.2% | 0.00% | 0.0% |
| Q1 2014 | $359,000 | +66.2% | 22,100 | +27.0% | 0.00% | +100.0% |
| Q4 2013 | $216,000 | +1.4% | 17,400 | -10.3% | 0.00% | 0.0% |
| Q3 2013 | $213,000 | +195.8% | 19,400 | +118.0% | 0.00% | – |
| Q2 2013 | $72,000 | – | 8,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |